Cited by 209Cholinesterase and Neurodegenerative DiseasesFlavonoids in Medical ResearchBioactive natural compounds

Structural Aspects of Flavonoids as Inhibitors of Human Butyrylcholinesterase

Katalinić, Maja, Rusak, Gordana, Domaćinović Barović, Jelena, Šinko, Goran, Jelić, Dubravko, Antolović, Roberto, Kovarik, Zrinka·2010·European Journal of Medicinal Chemistry

Abstract

Selected flavonoids: galangin, kaempferol, quercetin, myricetin, fisetin, apigenin, luteolin and rutin, reversibly inhibited human butyrylcholinesterase (BChE, EC 3.1.1.8). Inhibition potency of the flavonoids we attributed to their chemical structure, i.e., the number of OH groups and their side on the phenyl ring. The most potent BChE inhibitor among the tested flavonoids was galangin, which showed 12 times higher preference for binding to BChE (7 micromol/L) than to the related enzyme human acetylcholinesterase (AChE, EC 3.1.1.7). Docking study showed that flavonoids bind to the BChE active site by forming multiple hydrogen bonds and pi-pi interactions. The UV-VIS (200-500 nm) absorption spectra of the flavonoid phosphate buffer solution (pH 7.4), with the exception of rutin, revealed time dependant changes indicating precipitation of flavonoids or in the case of myricetin, a change in the chemical structure resulting in a BChE non-inhibiting specie. Selected flavonoids showed no cytotoxic effect on HepG2 and A549 cell lines at concentrations up to 200 micromol/L. Cytotoxicity was observed only for fisetin, apigenin and luteolin in the THP-1 cell line with IC50 of 30, 60 and 70 micromol/L, respectively.

Integrity signals

Registry

Crossref · 10.1016/j.ejmech.2009.09.041

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • During Alzheimer's disease progression, BChE activity can increase significantly, potentially contributing to aggregation of amyloid beta-peptides and formation of senile plaques.

    “Notably, during the progression of AD, BChE activity can increase significantly, potentially contributing to the aggregation of amyloid beta-peptides and the formation of senile plaques, which are characteristic of the disease [90,91].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Katalinić, M., Rusak, G., Domaćinović Barović, J., Šinko, G., Jelić, D., Antolović, R., & Kovarik, Z.
Affiliations
  • Institute for Medical Research and Occupational Health (HR)
  • University of Zagreb (HR)
  • GlaxoSmithKline (Croatia) (HR)
  • University of Rijeka (HR)
Corresponding author
Kovarik, Zrinka
Venue
European Journal of Medicinal Chemistry
Publisher
Elsevier BV
Published
2010-01
Volume
45
Issue
1
Pages
186-192
ISSN
0223-5234 (ISSN-L)
OpenAlex
W2084585115
Cited by
206
References
23
Citations by year
2026: 14 · 2025: 16 · 2024: 11 · 2023: 16 · 2022: 22 · 2021: 9 · 2020: 16 · 2019: 10 · 2018: 13 · 2017: 15 · 2016: 10 · 2015: 10 · 2014: 15 · 2013: 9 · 2012: 10
FWCI
5.29
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
  • Health Sciences › Medicine › Pharmacology › Flavonoids in Medical Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioactive natural compounds
Keywords
flavonoids, butyrylcholinesterase, acetylcholinesterase, enzyme inhibitors, structure-activity relationship, galangin, quercetin, kaempferol, myricetin, fisetin, apigenin, luteolin, rutin, molecular docking, hydrogen bonding, π-π stacking, cytotoxicity, THP-1 cells, HepG2 cells, A549 cells
MeSH terms
Acetylcholinesterase, Butyrylcholinesterase, Cholinesterase Inhibitors, Flavonoids, Humans, Models, Molecular, Protein Conformation, Substrate Specificity, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review